dilluns, 20 d’abril del 2015

LVADs: Thoratec study a Roadmap to lower-risk patients?

Results from Thoratec's Roadmap study of its HeartMate II implantable heart pump in less-sick heart failure patients shows significant benefit over optimal medical therapy alone.

LVADs: Thoratec study a Roadmap to lower-risk patients
HeartWare International Inc., International Society for Heart & Lung Transplantation, Thoratec Corp.
News Well, Clinical Trials, Cardiac Assist Devices

read more



from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zBDmO7
a

Cap comentari:

Publica un comentari a l'entrada